Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of 3 New Oral Hydromorphone Formulations vs Marketed Medication
NCT02446561Phase 1Completed
- Sponsor
- Mundipharma
- Start
- Apr 2015
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydromorphone in pain (4 arms), sponsored by Mundipharma. Primary endpoints: Area Under the Curve and Maximum Plasma Concentration. Started Apr 2015; status: completed.
02
Drugs
hydromorphone
03
Conditions
pain
Beyond the preview
Go deeper on NCT02446561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446561.